291 related articles for article (PubMed ID: 30384108)
1. Measurement of negative and depressive symptoms: Discriminatory relevance of affect and expression.
Richter J; Hölz L; Hesse K; Wildgruber D; Klingberg S
Eur Psychiatry; 2019 Jan; 55():23-28. PubMed ID: 30384108
[TBL] [Abstract][Full Text] [Related]
2. Self-assessment of negative symptoms - Critical appraisal of the motivation and pleasure - Self-report's (MAP-SR) validity and reliability.
Richter J; Hesse K; Eberle MC; Eckstein KN; Zimmermann L; Schreiber L; Burmeister CP; Wildgruber D; Klingberg S
Compr Psychiatry; 2019 Jan; 88():22-28. PubMed ID: 30466014
[TBL] [Abstract][Full Text] [Related]
3. The Swedish version of the Motivation and Pleasure Scale self-report (MAP-SR): psychometric properties in patients with schizophrenia or depression.
Cernvall M; Bengtsson J; Bodén R
Nord J Psychiatry; 2024 May; 78(4):339-346. PubMed ID: 38436927
[TBL] [Abstract][Full Text] [Related]
4. Concordance of self- and observer-rated motivation and pleasure in patients with negative symptoms and healthy controls.
Engel M; Lincoln TM
Psychiatry Res; 2017 Jan; 247():1-5. PubMed ID: 27863311
[TBL] [Abstract][Full Text] [Related]
5. The Motivation and Pleasure Scale-Self-Report (MAP-SR): reliability and validity of a self-report measure of negative symptoms.
Llerena K; Park SG; McCarthy JM; Couture SM; Bennett ME; Blanchard JJ
Compr Psychiatry; 2013 Jul; 54(5):568-74. PubMed ID: 23351831
[TBL] [Abstract][Full Text] [Related]
6. Motivation and Pleasure Scale-Self-Report (MAP-SR): Validation of the German version of a self-report measure for screening negative symptoms in schizophrenia.
Engel M; Lincoln TM
Compr Psychiatry; 2016 Feb; 65():110-5. PubMed ID: 26773998
[TBL] [Abstract][Full Text] [Related]
7. Evidence for two distinct domains of negative symptoms: Confirming the factorial structure of the CAINS.
Richter J; Hesse K; Schreiber L; Burmeister CP; Eberle MC; Eckstein KN; Zimmermann L; Wildgruber D; Klingberg S
Psychiatry Res; 2019 Jan; 271():693-701. PubMed ID: 30791343
[TBL] [Abstract][Full Text] [Related]
8. The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation.
Kring AM; Gur RE; Blanchard JJ; Horan WP; Reise SP
Am J Psychiatry; 2013 Feb; 170(2):165-72. PubMed ID: 23377637
[TBL] [Abstract][Full Text] [Related]
9. Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure.
Gard DE; Kring AM; Gard MG; Horan WP; Green MF
Schizophr Res; 2007 Jul; 93(1-3):253-60. PubMed ID: 17490858
[TBL] [Abstract][Full Text] [Related]
10. Negative Symptom Inventory-Self-Report (NSI-SR): Initial development and validation.
Raugh IM; Luther L; Bartolomeo LA; Gupta T; Ristanovic I; Pelletier-Baldelli A; Mittal VA; Walker EF; Strauss GP
Schizophr Res; 2023 Jun; 256():79-87. PubMed ID: 37172500
[TBL] [Abstract][Full Text] [Related]
11. Validation of the German version of the Clinical Assessment Interview for Negative Symptoms (CAINS).
Engel M; Fritzsche A; Lincoln TM
Psychiatry Res; 2014 Dec; 220(1-2):659-63. PubMed ID: 25138895
[TBL] [Abstract][Full Text] [Related]
12. Validation of the Spanish version of the Clinical Assessment for Negative Symptoms (CAINS).
Valiente-Gómez A; Mezquida G; Romaguera A; Vilardebò I; Andrés H; Granados B; Larrubia J; Pomarol-Clotet E; McKenna PJ; Sarró S; Bernardo M
Schizophr Res; 2015 Aug; 166(1-3):104-9. PubMed ID: 26116328
[TBL] [Abstract][Full Text] [Related]
13. Reward anticipation and trait anhedonia: An electrophysiological investigation in subjects with schizophrenia.
Vignapiano A; Mucci A; Ford J; Montefusco V; Plescia GM; Bucci P; Galderisi S
Clin Neurophysiol; 2016 Apr; 127(4):2149-60. PubMed ID: 26853737
[TBL] [Abstract][Full Text] [Related]
14. The Latent Structure of Negative Symptoms in Schizophrenia.
Strauss GP; Nuñez A; Ahmed AO; Barchard KA; Granholm E; Kirkpatrick B; Gold JM; Allen DN
JAMA Psychiatry; 2018 Dec; 75(12):1271-1279. PubMed ID: 30208377
[TBL] [Abstract][Full Text] [Related]
15. Validation and extension of the Motivation and Pleasure Scale-Self Report (MAP-SR) across the schizophrenia spectrum in the Chinese context.
Wang LL; Ma EPY; Lui SSY; Cheung EFC; Cheng KS; Chan RCK
Asian J Psychiatr; 2020 Mar; 49():101971. PubMed ID: 32065963
[TBL] [Abstract][Full Text] [Related]
16. Assessing negative symptoms in schizophrenia: Validity of the clinical assessment interview for negative symptoms in Singapore.
Rekhi G; Ang MS; Yuen CKY; Ng WY; Lee J
Schizophr Res; 2019 Apr; 206():177-182. PubMed ID: 30558979
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of instruments to measure depressive symptoms in patients with schizophrenia.
Lako IM; Bruggeman R; Knegtering H; Wiersma D; Schoevers RA; Slooff CJ; Taxis K
J Affect Disord; 2012 Sep; 140(1):38-47. PubMed ID: 22099566
[TBL] [Abstract][Full Text] [Related]
18. Initial development and preliminary validation of a new negative symptom measure: the Clinical Assessment Interview for Negative Symptoms (CAINS).
Forbes C; Blanchard JJ; Bennett M; Horan WP; Kring A; Gur R
Schizophr Res; 2010 Dec; 124(1-3):36-42. PubMed ID: 20869848
[TBL] [Abstract][Full Text] [Related]
19. [Validation of the Temporal Experience of Pleasure Scale (TEPS) in a French-speaking environment].
Favrod J; Ernst F; Giuliani F; Bonsack C
Encephale; 2009 Jun; 35(3):241-8. PubMed ID: 19540410
[TBL] [Abstract][Full Text] [Related]
20. Negative symptoms in schizophrenia: their evolution during an acute phase.
Dollfus S; Petit M
Schizophr Res; 1995 Oct; 17(2):187-94. PubMed ID: 8562493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
